humanitarian
biggovernment
secondamendment
firstamendment
freedom
News & Articles By Willow Tohi
04/01/2025
/
By Willow Tohi
European Court of Justice: Healthcare professionals who promoted or administered COVID-19 vaccines are CRIMINALLY LIABLE for any harm caused
The European Court of Justice (ECJ) ruled in 2025 that healthcare professionals promoting or administering COVID-19 vaccines are civilly and criminally liable for harm caused, as they had the autonomy to refuse participation. In 2020, Dr. Vernon Coleman warned that doctors prescribing experimental COVID-19 vaccines could face lawsuits and imprisonment if harm occurred—a prediction now […]
03/31/2025
/
By Willow Tohi
RFK Jr. is reforming Americans’ health: A shift in power and paradigm
Secretary RFK Jr. is streamlining the Department of Health and Human Services (HHS), cutting 19,000 jobs, consolidating divisions and centralizing key functions to reduce inefficiency and redundancies. Kennedy supports Susan Monarez, a non-physician with a microbiology Ph.D., as CDC director, sparking debate. He also defended the resignation of FDA vaccine chief Peter Marks, calling it […]
03/31/2025
/
By Willow Tohi
EPA banned chemical linked to cancer, Parkinson’s and fatal heart defects in babies — now industry is lobbying to get it reinstated
The EPA banned trichloroethylene (TCE) in December 2024 due to its carcinogenic and neurodegenerative effects, but industry groups and some lawmakers are pushing to repeal the ban, risking public health. TCE exposure is linked to cancers (liver, kidney, non-Hodgkin lymphoma), Parkinson’s disease, and life-threatening heart defects in infants, with documented cases in contaminated areas like […]
03/30/2025
/
By Willow Tohi
Gold reaches all-time high amid escalating trade tensions
Gold prices surged to an all-time high ($3,086.70/oz) amid escalating U.S.-led trade tensions, marking its 18th record this year as investors sought safe-haven assets. President Trump’s new 25% tariffs on foreign-made cars and parts sparked fears of retaliation (e.g., Canada, EU), worsening risk sentiment and boosting gold demand. Wall Street declined, and the U.S. Dollar […]
03/30/2025
/
By Willow Tohi
U.K. unveils controversial pandemic preparedness tool: A double-edged sword?
The U.K. government has introduced a tool to map vulnerable groups (based on age, disability and care status) to provide “targeted support” during crises. Critics warn it risks privacy violations and overreach. The tool is part of a broader effort to address gaps exposed by the COVID-19 Inquiry, including the largest national pandemic exercise in […]
03/29/2025
/
By Willow Tohi
NIH to crack down on taxpayer-funded censorship: A victory for academic freedom
STAT News initially (and incorrectly) claimed the NIH directive to compile grants related to “fighting misinformation” was issued on Jay Bhattacharya’s first day as director. However, Bhattacharya had not yet been sworn in, highlighting scrutiny around his nomination. The NIH instructed staff to identify contracts tied to censorship or influencing health beliefs, including keywords like […]
03/29/2025
/
By Willow Tohi
Is the vaccine-autism debate reopening? Washington Post sparks controversy with preemptive hit piece on David Geier
David Geier, a researcher with expertise in thimerosal and vaccine-related data, has been tapped by the U.S. Department of Health and Human Services (HHS) to lead a study on the potential links between vaccines and autism, sparking significant controversy and debate. The Washington Post published an article, citing anonymous officials, that criticizes Geier’s appointment, labeling […]
03/28/2025
/
By Willow Tohi
The great crypto power struggle: How technocrats and governments are reshaping global finance
Governments, central banks and technocrats are engaged in a fierce battle for control over the future of money, with the obsolescence of cash, weaponization of cryptocurrencies and pervasive surveillance at the core of this high-stakes conflict. The conflict has roots in the 1932 ideology of Technocracy, which seeks governance by scientists and engineers. Modern proponents, […]
03/28/2025
/
By Willow Tohi
Gabbard, Patel defend FISA Section 702 amid privacy concerns in contentious Senate hearing
Director of National Intelligence Tulsi Gabbard and FBI Director Kash Patel defended the warrantless surveillance tool, facing bipartisan scrutiny over its impact on Americans’ Fourth Amendment rights. The hearing highlighted the ongoing debate over the balance between national security needs and protecting citizens’ privacy, with Section 702 set to expire unless reauthorized. Gabbard and Patel […]
03/28/2025
/
By Willow Tohi
Trump rescinds Stefanik’s UN ambassador nomination, citing narrow Republican majority
President Donald Trump has rescinded Rep. Elise Stefanik’s nomination for UN ambassador, citing concerns over maintaining the Republican majority in the House of Representatives. The decision marks a strategic shift aimed at solidifying Trump’s base and ensuring critical votes in Congress are secured, given the narrow five-seat Republican majority. Stefanik, a staunch Trump supporter, stepped […]
« Previous Page
82 of 124
Next Page »
Get Our Free Email Newsletter
Get independent news alerts on natural cures, food lab tests, cannabis medicine, science, robotics, drones, privacy and more.
Your privacy is protected.
Subscription confirmation required.
Popular Articles
Get Our Free Email Newsletter
Get independent news alerts on natural cures, food lab tests, cannabis medicine, science, robotics, drones, privacy and more.
Subscription confirmation required.
We respect your privacy
and do not share emails with anyone. You can easily unsubscribe at any time.
COPYRIGHT © 2017 BIG GOVERNMENT NEWS
Privacy Policy
Get Our Free Email Newsletter
Get independent news alerts on natural cures, food lab tests, cannabis medicine, science, robotics, drones, privacy and more.
Subscription confirmation required.
We respect your privacy
and do not share emails with anyone. You can easily unsubscribe at any time.
Close
x
By continuing to browse our site you agree to our use of cookies and our
Privacy Policy
.
Agree and close